SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-031420
Filing Date
2008-05-14
Accepted
2008-05-14 18:40:54
Documents
1
Period of Report
2008-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd206827.html 4  
1 FORM 4 rrd206827.xml 4 5123
  Complete submission text file 0001181431-08-031420.txt   7053
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 435 TASSO STREET SUITE 305 PALO ALTO CA 94301
Business Address 435 TASSO STREET SUITE 305 PALO ALTO CA 94301 6505431555
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP (Reporting) CIK: 0001367998 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 08833443